[HTML][HTML] Functionalized liposomes for targeted breast cancer drug delivery

J Nel, K Elkhoury, É Velot, A Bianchi, S Acherar… - Bioactive materials, 2023 - Elsevier
Despite the exceptional progress in breast cancer pathogenesis, prognosis, diagnosis, and
treatment strategies, it remains a prominent cause of female mortality worldwide …

Antinuclear autoantibodies in health: autoimmunity is not a synonym of autoimmune disease

IA Pashnina, IM Krivolapova, TV Fedotkina… - Antibodies, 2021 - mdpi.com
The incidence of autoimmune diseases is increasing. Antinuclear antibody (ANA) testing is a
critical tool for their diagnosis. However, ANA prevalence in healthy persons has increased …

Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors

ATJ Maria, L Partouche, R Goulabchand… - Frontiers in …, 2019 - frontiersin.org
Systemic sclerosis (SSc) is an autoimmune connective tissue disorder, characterized by
multisystem involvement, vasculopathy, and fibrosis. An increased risk of malignancy is …

Gene expression analysis in endometriosis: Immunopathology insights, transcription factors and therapeutic targets

R Geng, X Huang, L Li, X Guo, Q Wang… - Frontiers in …, 2022 - frontiersin.org
Background Endometriosis is recognized as an estrogen-dependent inflammation disorder,
estimated to affect 8%-15% of women of childbearing age. Currently, the etiology and …

[HTML][HTML] Protein citrullination as a source of cancer neoantigens

H Katayama, M Kobayashi, E Irajizad… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Citrulline post-translational modification of proteins is mediated by protein
arginine deiminase (PADI) family members and has been associated with autoimmune …

Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies

T Sakakida, T Ishikawa, Y Chihara, S Harita… - Clinical and …, 2020 - Springer
Abstract Purpose Immune checkpoint inhibitors (ICIs) show promising clinical activity in
advanced cancers. However, the safety and efficacy of PD-1/PD-L1 blockade in patients with …

Anti-cancer auto-antibodies: Roles, applications and open issues

H de Jonge, L Iamele, M Maggi, G Pessino, C Scotti - Cancers, 2021 - mdpi.com
Simple Summary Cancer is one of the main causes of death worldwide and early detection
is crucial for effective treatment. Scientists have therefore focused on the identification of …

Evaluation of autoantibodies as predictors of treatment response and immune‐related adverse events during the treatment with immune checkpoint inhibitors: a …

DA Barth, S Stanzer, J Spiegelberg… - Cancer …, 2022 - Wiley Online Library
Background The presence of autoantibodies in the serum of cancer patients has been
associated with immune‐checkpoint inhibitor (ICI) therapy response and immune‐related …

Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease

JT Zanussi, J Zhao, WQ Wei, G Karakoc, CP Chung… - BMC rheumatology, 2023 - Springer
Background Antinuclear antibodies (ANA) are antibodies present in several autoimmune
disorders. However, a large proportion of the general population (20%) also have a positive …

Association between changes in the patterns of antinuclear autoantibodies during immune checkpoint inhibition therapy and the development of severe immune …

L Alserawan, G Anguera, C Zamora Atenza… - International journal of …, 2022 - mdpi.com
Immune-related adverse events (irAEs) are unpredictable autoimmune-like toxicities
induced by immune checkpoint inhibitors (ICI). irAEs are a consequence of a breakdown in …